16-1211550-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021098.3(CACNA1H):c.4420C>T(p.Arg1474Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000399 in 1,612,216 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1H | NM_021098.3 | c.4420C>T | p.Arg1474Trp | missense_variant | 23/35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.4420C>T | p.Arg1474Trp | missense_variant | 23/35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.4420C>T | p.Arg1474Trp | missense_variant | 22/33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.4381C>T | p.Arg1461Trp | missense_variant | 23/35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000569107.5 | c.643C>T | p.Arg215Trp | missense_variant | 6/17 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000564231.5 | c.643C>T | p.Arg215Trp | missense_variant | 6/18 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000562079.5 | c.643C>T | p.Arg215Trp | missense_variant | 6/17 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000639478.1 | n.4420C>T | non_coding_transcript_exon_variant | 23/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*2333C>T | non_coding_transcript_exon_variant | 23/35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000640028.1 | n.*2333C>T | 3_prime_UTR_variant | 23/35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.00191 AC: 291AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000536 AC: 132AN: 246262Hom.: 0 AF XY: 0.000365 AC XY: 49AN XY: 134350
GnomAD4 exome AF: 0.000242 AC: 353AN: 1459884Hom.: 1 Cov.: 35 AF XY: 0.000205 AC XY: 149AN XY: 726222
GnomAD4 genome AF: 0.00191 AC: 291AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.00177 AC XY: 132AN XY: 74484
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2022 | The c.4420C>T (p.R1474W) alteration is located in exon 23 (coding exon 22) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 4420, causing the arginine (R) at amino acid position 1474 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 09, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 26, 2017 | - - |
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at